Inventory / revenue moved 229 bp higher
Inventory / revenue changed +229 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed +229 basis points from the comparable as-filed period.
Revenue changed +3.8% from the comparable as-filed period.
Net income changed -12.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +0.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross profit changed +7.3% from the comparable as-filed period.
Inventory changed +6.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
SBC / revenue changed -18 basis points from the comparable as-filed period.
Selling, general & administrative changed +1.1% from the comparable as-filed period.
Stock-based compensation changed -1.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.